{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:04:14Z","timestamp":1781647454593,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hotung Sai Kim Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13882-8","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:27:12Z","timestamp":1754612832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The therapeutic potential of pegylated arginase I treatment in glioblastoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Marcus Kwong Lam","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"De Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto Ka Kit","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey Chi Fung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"13882_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong, L., Li, N. & Zhang, Z. Emerging therapies for glioblastoma: current state and future directions. J. Exp. Clin. Cancer Res. 41, 142. https:\/\/doi.org\/10.1186\/s13046-022-02349-7 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"13882_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22034\/APJCP.2017.18.1.3","volume":"18","author":"F Hanif","year":"2017","unstructured":"Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M. & Simjee, S. U. Glioblastoma Multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac. J. Cancer Prev. 18, 3\u20139. https:\/\/doi.org\/10.22034\/APJCP.2017.18.1.3 (2017).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"13882_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111536","author":"RS Angom","year":"2023","unstructured":"Angom, R. S., Nakka, N. M. R. & Bhattacharya, S. Advances in glioblastoma therapy: An update on current approaches. Brain Sci https:\/\/doi.org\/10.3390\/brainsci13111536 (2023).","journal-title":"Brain Sci"},{"key":"13882_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jso.24490","volume":"115","author":"VL Albaugh","year":"2017","unstructured":"Albaugh, V. L., Pinzon-Guzman, C. & Barbul, A. Arginine-Dual roles as an onconutrient and immunonutrient. J. Surg. Oncol. 115, 273\u2013280. https:\/\/doi.org\/10.1002\/jso.24490 (2017).","journal-title":"J. Surg. Oncol."},{"key":"13882_CR5","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1038\/onc.2016.37","volume":"35","author":"MD Patil","year":"2016","unstructured":"Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C. & Fukumura, D. Arginine dependence of tumor cells: Targeting a chink in cancer\u2019s armor. Oncogene 35, 4957\u20134972. https:\/\/doi.org\/10.1038\/onc.2016.37 (2016).","journal-title":"Oncogene"},{"key":"13882_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13045-017-0509-9","volume":"10","author":"MKL Fung","year":"2017","unstructured":"Fung, M. K. L. & Chan, G. C. Drug-induced amino acid deprivation as strategy for cancer therapy. J Hematol Oncol 10, 144. https:\/\/doi.org\/10.1186\/s13045-017-0509-9 (2017).","journal-title":"J Hematol Oncol"},{"key":"13882_CR7","doi-asserted-by":"publisher","first-page":"63506","DOI":"10.18632\/oncotarget.18843","volume":"8","author":"A Vardon","year":"2017","unstructured":"Vardon, A. et al. Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies. Oncotarget 8, 63506\u201363517. https:\/\/doi.org\/10.18632\/oncotarget.18843 (2017).","journal-title":"Oncotarget"},{"key":"13882_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-022-05006-1","volume":"13","author":"C Riess","year":"2022","unstructured":"Riess, C. et al. Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells. Cell Death Dis. 13, 555. https:\/\/doi.org\/10.1038\/s41419-022-05006-1 (2022).","journal-title":"Cell Death Dis."},{"key":"13882_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10637-022-01265-z","volume":"40","author":"SF Chung","year":"2022","unstructured":"Chung, S. F. et al. Mono-PEGylated thermostable Bacillus caldovelox arginase mutant (BCA-M-PEG20) induces apoptosis, autophagy, cell cycle arrest and growth inhibition in gastric cancer cells. Invest New Drugs 40, 895\u2013904. https:\/\/doi.org\/10.1007\/s10637-022-01265-z (2022).","journal-title":"Invest New Drugs"},{"key":"13882_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/cb900267j","volume":"5","author":"EM Stone","year":"2010","unstructured":"Stone, E. M. et al. Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines. ACS Chem. Biol. 5, 333\u2013342. https:\/\/doi.org\/10.1021\/cb900267j (2010).","journal-title":"ACS Chem. Biol."},{"key":"13882_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12935-020-01232-9","volume":"20","author":"H Al-Koussa","year":"2020","unstructured":"Al-Koussa, H., El Mais, N., Maalouf, H., Abi-Habib, R. & El-Sibai, M. Arginine deprivation: A potential therapeutic for cancer cell metastasis? A review. Cancer Cell Int. 20, 150. https:\/\/doi.org\/10.1186\/s12935-020-01232-9 (2020).","journal-title":"Cancer Cell Int."},{"key":"13882_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052150","author":"GC Field","year":"2023","unstructured":"Field, G. C., Pavlyk, I. & Szlosarek, P. W. Bench-to-bedside studies of arginine deprivation in cancer. Molecules https:\/\/doi.org\/10.3390\/molecules28052150 (2023).","journal-title":"Molecules"},{"key":"13882_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tem.2021.03.003","volume":"32","author":"M Butler","year":"2021","unstructured":"Butler, M., van der Meer, L. T. & van Leeuwen, F. N. Amino acid depletion therapies: Starving cancer cells to death. Trends Endocrinol Metab 32, 367\u2013381. https:\/\/doi.org\/10.1016\/j.tem.2021.03.003 (2021).","journal-title":"Trends Endocrinol Metab"},{"key":"13882_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s10637-021-01178-3","volume":"40","author":"T Yau","year":"2022","unstructured":"Yau, T. et al. A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients. Invest New Drugs 40, 314\u2013321. https:\/\/doi.org\/10.1007\/s10637-021-01178-3 (2022).","journal-title":"Invest New Drugs"},{"key":"13882_CR15","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/annonc\/mdy101","volume":"29","author":"GK Abou-Alfa","year":"2018","unstructured":"Abou-Alfa, G. K. et al. Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Ann Oncol 29, 1402\u20131408. https:\/\/doi.org\/10.1093\/annonc\/mdy101 (2018).","journal-title":"Ann Oncol"},{"key":"13882_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10637-021-01111-8","volume":"39","author":"SL Chan","year":"2021","unstructured":"Chan, S. L. et al. A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma. Invest New Drugs 39, 1375\u20131382. https:\/\/doi.org\/10.1007\/s10637-021-01111-8 (2021).","journal-title":"Invest New Drugs"},{"key":"13882_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217680","volume":"620","author":"T Feng","year":"2025","unstructured":"Feng, T. et al. The arginine metabolism and its deprivation in cancer therapy. Cancer Lett 620, 217680. https:\/\/doi.org\/10.1016\/j.canlet.2025.217680 (2025).","journal-title":"Cancer Lett"},{"key":"13882_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109210","volume":"118","author":"S Zou","year":"2019","unstructured":"Zou, S., Wang, X., Liu, P., Ke, C. & Xu, S. Arginine metabolism and deprivation in cancer therapy. Biomed Pharmacother 118, 109210. https:\/\/doi.org\/10.1016\/j.biopha.2019.109210 (2019).","journal-title":"Biomed Pharmacother"},{"key":"13882_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/15384047.2015.1026478","volume":"16","author":"T Fiedler","year":"2015","unstructured":"Fiedler, T. et al. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer Biol Ther 16, 1047\u20131055. https:\/\/doi.org\/10.1080\/15384047.2015.1026478 (2015).","journal-title":"Cancer Biol Ther"},{"key":"13882_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142137","author":"N Hajji","year":"2022","unstructured":"Hajji, N. et al. Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI142137 (2022).","journal-title":"J. Clin. Invest."},{"key":"13882_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41419-018-1195-4","volume":"9","author":"JM Przystal","year":"2018","unstructured":"Przystal, J. M. et al. Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM. Cell Death Dis. 9, 1192. https:\/\/doi.org\/10.1038\/s41419-018-1195-4 (2018).","journal-title":"Cell Death Dis."},{"key":"13882_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-014-1698-5","volume":"122","author":"O Khoury","year":"2015","unstructured":"Khoury, O. et al. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J. Neurooncol. 122, 75\u201385. https:\/\/doi.org\/10.1007\/s11060-014-1698-5 (2015).","journal-title":"J. Neurooncol."},{"key":"13882_CR23","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.18632\/oncotarget.18026","volume":"8","author":"S Sun","year":"2017","unstructured":"Sun, S. et al. Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling. Oncotarget 8, 1911\u201371923. https:\/\/doi.org\/10.18632\/oncotarget.18026 (2017).","journal-title":"Oncotarget"},{"key":"13882_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2162-3619-2-11","volume":"2","author":"F Kwong-Lam","year":"2013","unstructured":"Kwong-Lam, F. & Chi-Fung, C. G. Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment. Exp. Hematol. Oncol. 2, 11. https:\/\/doi.org\/10.1186\/2162-3619-2-11 (2013).","journal-title":"Exp. Hematol. Oncol."},{"key":"13882_CR25","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"13882_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res"},{"key":"13882_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s13205-022-03326-9","volume":"12","author":"J Anakha","year":"2022","unstructured":"Anakha, J. et al. Human arginase 1, a Jack of all trades?. 3 Biotech 12, 264. https:\/\/doi.org\/10.1007\/s13205-022-03326-9 (2022).","journal-title":"3 Biotech"},{"key":"13882_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12936-019-3072-8","volume":"18","author":"LWP de Sena","year":"2019","unstructured":"de Sena, L. W. P. et al. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin. Malar J 18, 439. https:\/\/doi.org\/10.1186\/s12936-019-3072-8 (2019).","journal-title":"Malar J"},{"key":"13882_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143541","author":"CL Chen","year":"2021","unstructured":"Chen, C. L., Hsu, S. C., Ann, D. K., Yen, Y. & Kung, H. J. Arginine signaling and cancer metabolism. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13143541 (2021).","journal-title":"Cancers (Basel)"},{"key":"13882_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092028","author":"M Scalise","year":"2020","unstructured":"Scalise, M. et al. Membrane transporters for amino acids as players of cancer metabolic rewiring. Cells https:\/\/doi.org\/10.3390\/cells9092028 (2020).","journal-title":"Cells"},{"key":"13882_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310668","author":"YD Chu","year":"2023","unstructured":"Chu, Y. D., Lai, M. W. & Yeh, C. T. Unlocking the potential of arginine deprivation therapy: Recent breakthroughs and promising future for cancer treatment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241310668 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"13882_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11060-019-03318-5","volume":"147","author":"LR Olafson","year":"2020","unstructured":"Olafson, L. R., Gunawardena, M., Nixdorf, S., McDonald, K. L. & Rapkins, R. W. The role of TP53 gain-of-function mutation in multifocal glioblastoma. J. Neurooncol. 147, 37\u201347. https:\/\/doi.org\/10.1007\/s11060-019-03318-5 (2020).","journal-title":"J. Neurooncol."},{"key":"13882_CR33","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jnci\/djab019","volume":"113","author":"C De Souza","year":"2021","unstructured":"De Souza, C. et al. Effect of the p53 P72R polymorphism on mutant TP53 allele selection in human cancer. J. Natl. Cancer Inst. 113, 1246\u20131257. https:\/\/doi.org\/10.1093\/jnci\/djab019 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"13882_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s42003-018-0178-4","volume":"1","author":"CT Cheng","year":"2018","unstructured":"Cheng, C. T. et al. Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction. Commun. Biol. 1, 178. https:\/\/doi.org\/10.1038\/s42003-018-0178-4 (2018).","journal-title":"Commun. Biol."},{"key":"13882_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.733688","volume":"9","author":"AA Artykov","year":"2021","unstructured":"Artykov, A. A. et al. Death receptors DR4 and DR5 undergo spontaneous and ligand-mediated endocytosis and recycling regardless of the sensitivity of cancer cells to TRAIL. Front Cell Dev. Biol. 9, 733688. https:\/\/doi.org\/10.3389\/fcell.2021.733688 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"13882_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.628332","volume":"8","author":"M Snajdauf","year":"2021","unstructured":"Snajdauf, M. et al. The TRAIL in the treatment of human cancer: An update on clinical trials. Front Mol. Biosci. 8, 628332. https:\/\/doi.org\/10.3389\/fmolb.2021.628332 (2021).","journal-title":"Front Mol. Biosci."},{"key":"13882_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.582587","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Amino acid degrading enzymes and autophagy in cancer therapy. Front Pharmacol. 11, 582587. https:\/\/doi.org\/10.3389\/fphar.2020.582587 (2020).","journal-title":"Front Pharmacol."},{"key":"13882_CR38","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3892\/or.2018.6598","volume":"40","author":"SK Lam","year":"2018","unstructured":"Lam, S. K. et al. Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models. Oncol. Rep. 40, 1994\u20132004. https:\/\/doi.org\/10.3892\/or.2018.6598 (2018).","journal-title":"Oncol. Rep."},{"key":"13882_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/bjc.2011.524","volume":"106","author":"MP Kelly","year":"2012","unstructured":"Kelly, M. P. et al. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase. Br. J. Canc. 106, 324\u2013332. https:\/\/doi.org\/10.1038\/bjc.2011.524 (2012).","journal-title":"Br. J. Canc."},{"issue":"Suppl 9","key":"13882_CR40","first-page":"28","volume":"25","author":"SL Leung","year":"2019","unstructured":"Leung, S. L. et al. PEGylated recombinant human arginase as a drug for breast cancer. Hong Kong Med J. 25(Suppl 9), 28\u201331 (2019).","journal-title":"Hong Kong Med J."},{"key":"13882_CR41","doi-asserted-by":"publisher","first-page":"5510663","DOI":"10.1155\/2021\/5510663","volume":"2021","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Pegylated recombinant human arginase 1 induces autophagy and apoptosis via the ROS-activated AKT\/mTOR pathway in bladder cancer cells. Oxid Med. Cell Longev 2021, 5510663. https:\/\/doi.org\/10.1155\/2021\/5510663 (2021).","journal-title":"Oxid Med. Cell Longev"},{"key":"13882_CR42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4161\/auto.2966","volume":"2","author":"W Martinet","year":"2006","unstructured":"Martinet, W., Schrijvers, D. M., Herman, A. G. & De Meyer, G. R. z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilization. Autophagy 2, 312\u2013314. https:\/\/doi.org\/10.4161\/auto.2966 (2006).","journal-title":"Autophagy"},{"key":"13882_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/cdd.2010.72","volume":"18","author":"YT Wu","year":"2011","unstructured":"Wu, Y. T. et al. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 18, 26\u201337. https:\/\/doi.org\/10.1038\/cdd.2010.72 (2011).","journal-title":"Cell Death Differ"},{"key":"13882_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Chen, X., Gueydan, C. & Han, J. Plasma membrane changes during programmed cell deaths. Cell Res 28, 9\u201321. https:\/\/doi.org\/10.1038\/cr.2017.133 (2018).","journal-title":"Cell Res"},{"key":"13882_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.197","volume":"4","author":"N Syed","year":"2013","unstructured":"Syed, N. et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis. 4, e458. https:\/\/doi.org\/10.1038\/cddis.2012.197 (2013).","journal-title":"Cell Death Dis."},{"key":"13882_CR46","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.drudis.2020.09.010","volume":"25","author":"W Zhou","year":"2020","unstructured":"Zhou, W. et al. Chloroquine against malaria, cancers and viral diseases. Drug Discov Today 25, 2012\u20132022. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.010 (2020).","journal-title":"Drug Discov Today"},{"key":"13882_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/15548627.2017.1409926","volume":"14","author":"B Jutten","year":"2018","unstructured":"Jutten, B. et al. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy 14, 283\u2013295. https:\/\/doi.org\/10.1080\/15548627.2017.1409926 (2018).","journal-title":"Autophagy"},{"key":"13882_CR48","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3332\/ecancer.2017.781","volume":"11","author":"C Verbaanderd","year":"2017","unstructured":"Verbaanderd, C. et al. Repurposing drugs in oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience 11, 781. https:\/\/doi.org\/10.3332\/ecancer.2017.781 (2017).","journal-title":"Ecancermedicalscience"},{"key":"13882_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174255","author":"RS Andersen","year":"2021","unstructured":"Andersen, R. S., Anand, A., Harwood, D. S. L. & Kristensen, B. W. Tumor-Associated microglia and macrophages in the glioblastoma microenvironment and their implications for therapy. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13174255 (2021).","journal-title":"Cancers (Basel)"},{"key":"13882_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163446","author":"F Khan","year":"2023","unstructured":"Khan, F. et al. Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy. J Clin Invest https:\/\/doi.org\/10.1172\/JCI163446 (2023).","journal-title":"J Clin Invest"},{"key":"13882_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuron.2019.08.028","volume":"104","author":"DH Gutmann","year":"2019","unstructured":"Gutmann, D. H. & Kettenmann, H. Microglia\/brain macrophages as central drivers of brain tumor pathobiology. Neuron 104, 442\u2013449. https:\/\/doi.org\/10.1016\/j.neuron.2019.08.028 (2019).","journal-title":"Neuron"},{"key":"13882_CR52","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","volume":"127","author":"J Li","year":"2004","unstructured":"Li, J., Law, H. K., Lau, Y. L. & Chan, G. C. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br. J. Haematol. 127, 326\u2013334. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05200.x (2004).","journal-title":"Br. J. Haematol."},{"key":"13882_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2020.02.001","volume":"220","author":"S Sultana","year":"2020","unstructured":"Sultana, S. & Bishayi, B. Etoposide-mediated depletion of peripheral blood monocytes post s.aureus infection attenuates septic arthritis by modulating macrophage-derived factors responsible for inflammatory destruction. Immunol. Lett. 220, 51\u201362. https:\/\/doi.org\/10.1016\/j.imlet.2020.02.001 (2020).","journal-title":"Immunol. Lett."},{"key":"13882_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12060718","author":"G Menna","year":"2022","unstructured":"Menna, G. et al. Glioma-associated microglia characterization in the glioblastoma microenvironment through a \u201cseed-and soil\u201d approach: A systematic review. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12060718 (2022).","journal-title":"Brain Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13882-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:02:33Z","timestamp":1755003753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13882"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13882-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study was approved by the Committee on the Use of Live Animals for Teaching and Research (CULATR) of The University of Hong Kong. All methods were performed in accordance with the relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"28994"}}